Business context and reporting period
The Chefs’ Warehouse, Inc. distributes specialty foods and other foodservice products, principally to independent restaurants and other culinary businesses. This unaudited Form 10-Q covers the 13 weeks and 39 weeks ended September 25, 2020; comparisons are with periods ended September 27, 2019. Results were materially affected by COVID-19 restrictions and reduced restaurant demand.
Key financial results
| Metric | 13 weeks ended September 25, 2020 | 39 weeks ended September 25, 2020 |
|---|---|---|
| Net sales | $254.0 million; down 36.0% | $830.0 million; down 28.8% |
| Gross profit and margin | $60.6 million; 23.9% vs. 24.5% | $190.3 million; 22.9% vs. 24.5% |
| Operating income (loss) | $(11.9) million | $(54.4) million |
| Net income (loss) | $(11.4) million; $(0.31) per diluted share | $(45.8) million; $(1.39) per diluted share |
| Cash provided by operating activities | Not separately provided for the quarter | $53.9 million, compared with $23.5 million |
Quarterly SG&A was $76.7 million (30.2% of sales), down 8.6% in dollars year over year; for the 39 weeks it was $254.5 million, up 3.0%. Other operating income was $4.1 million in the quarter and $9.8 million year to date, primarily reflecting non-cash reductions in contingent earn-out liabilities. Interest expense was $4.7 million for the quarter and $15.6 million year to date.
At September 25, 2020, cash and cash equivalents were $208.5 million. Total current assets were $438.8 million and total current liabilities were $135.1 million. Debt obligations were $402.5 million carrying value, including $40.0 million drawn on the asset-based loan facility and $14.8 million of finance lease and other financing obligations. The company reported $44.3 million of remaining ABL borrowing availability, $250.4 million of minimum liquidity under its credit agreement, and compliance with all debt covenants. The filing’s selected-liquidity table reports $347.9 million, comprising cash, working capital excluding cash, and ABL availability.
Material changes versus the prior comparable periods
- COVID-19 drove organic sales declines of $178.1 million, or 44.9%, in the quarter and $439.2 million, or 37.7%, for the 39 weeks. Acquisitions contributed $35.3 million and $103.9 million, respectively.
- Quarterly specialty-category case count declined approximately 49.3%; center-of-the-plate pounds sold declined 45.4%. Year-to-date declines were 42.1% and 36.9%, respectively.
- Year-to-date operating cash flow rose despite the net loss, principally because reduced demand released $64.5 million of working capital. Investing cash outflow was $65.8 million, including $60.4 million for acquisitions; financing cash inflow was $80.5 million, including equity proceeds.
- The company issued 6.6 million common shares in May and June, raising approximately $85.9 million net. Shares outstanding increased from 30.3 million at December 27, 2019 to 37.8 million at September 25, 2020.
- The company acquired Sid Wainer & Son for approximately $44.1 million and another New England specialty distributor for approximately $16.4 million. Sid Wainer contributed $66.5 million of year-to-date sales and recorded a $5.6 million operating loss.
- The company amended its term loan in June, extending the maturity of a $170.8 million tranche to 2025 while increasing its rate to LIBOR plus 5.5%; the remaining $31.2 million tranche matures in 2022. The amendment also introduced a minimum-liquidity covenant.
Outlook, management commentary, risks and unusual items
- Management said the duration and effects of COVID-19 were uncertain. It pursued retail and direct-to-consumer channels, adjusted purchasing toward in-demand products, and reduced costs through compensation actions and deferred capital spending.
- Fiscal 2020 capital expenditures, excluding acquisitions, were expected to be $8–$10 million, reduced from the original $38–$42 million estimate. Management believed cash, working capital and ABL availability were sufficient for requirements over the next 12 months; no sales or earnings guidance was provided.
- COVID-19 led to estimated non-cash charges of $15.8 million for incremental bad debt and approximately $9.8 million for inventory obsolescence during the 39 weeks. Specialty gross margins were pressured by mix and inventory losses, while center-of-the-plate margins benefited from higher retail sales.
- Interim goodwill and long-lived asset tests performed in March found no impairment; management reported no further triggering events in the second or third quarters but warned that future impairment charges remain possible.
- The company reclassified food processing costs from operating expenses to cost of sales and revised operating-expense presentation following SEC staff comments. The reclassifications did not affect operating income, net income or cash flows. The filing also disclosed a non-material prior-period error in weighted-average shares that had understated second-quarter 2020 loss per share; those figures were restated.
- The CARES Act enabled an expected income tax refund receivable of $21.0 million. A 100-basis-point rise in market rates was estimated to reduce annual after-tax earnings by approximately $1.6 million. Management said ordinary-course litigation was not expected to have a material adverse effect.
Important facts for investors to verify
- Whether restaurant capacity restrictions and customer demand recover, and how that affects organic sales, margins, receivables and inventory.
- Whether the expected tax refund is realized and whether elevated bad-debt and inventory reserves prove adequate.
- Debt maturity, interest-rate exposure, covenant headroom and the availability of ABL financing as operating conditions evolve.
- Acquisition performance, including Sid Wainer’s operating losses and any contingent earn-out payments.
- Potential future impairment charges and the assumptions supporting the company’s March impairment assessments.
- The impact of the equity issuance on per-share results and the restated second-quarter share-count and EPS figures.